affiliate disclosure · We earn affiliate commission on some vendor links. Audits, scores, and rankings are independent — vendors do not pay for placement and do not see drafts. read more →
Cagrilintide vs Tesamorelin
Two compounds, mechanism by mechanism. Where they overlap, where they don't, and which vendors stock each.
§ 01
Mechanism
cagrilintide
Cagrilintide
AM833long-acting amylin analog
Synthetic long-acting amylin analog. Activates amylin and calcitonin receptors. Studied in combination with semaglutide as CagriSema in Phase 3 obesity trials.
Full guide →vs
tesamorelin
Tesamorelin
TH9507Egrifta
Synthetic 44-amino-acid analog of growth hormone-releasing hormone (GHRH). Stimulates pituitary release of endogenous growth hormone in a pulsatile manner.
Full guide →§ 02
Key facts
§ 03
Use-case overlap
only cagrilintide
- weight management research
- amylin-analog studies
- GLP-1 combination protocols
both
none
only tesamorelin
- visceral fat reduction
- GHRH analog research
- HIV-associated lipodystrophy (FDA-approved indication)
§ 04
Where to buy
§ 05
Sources
- [01]Cagrilintide and semaglutide combination — The Lancet· Cagrilintide
- [02]Novo Nordisk CagriSema Phase 3 program· Cagrilintide
- [03]Effects of tesamorelin on visceral adipose tissue — JAMA· Tesamorelin
- [04]FDA approval label — Egrifta· Tesamorelin
read next
Other peptide matchups
the roundup · monthly
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.
14,200 subscribers· 0 sponsored items· 11 issues since launch